4.6 Article

Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma

Journal

BMC CANCER
Volume 11, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/1471-2407-11-126

Keywords

esophageal carcinoma cell-free DNA; erbB2 copy number variation; prognostic marker; CTCs

Categories

Funding

  1. Associazione Italiana per la Ricerca sul Cancro (AIRC)
  2. [HEALTH-F2-2008-201662]

Ask authors/readers for more resources

Background: Mortality is high in patients with esophageal carcinoma as tumors are rarely detected before the disease has progressed to an advanced stage. Here, we sought to isolate cell-free DNA released into the plasma of patients with esophageal carcinoma, to analyze copy number variations of marker genes in the search for early detection of tumor progression. Methods: Plasma of 41 patients with esophageal carcinoma was prospectively collected before tumor resection and chemotherapy. Our dataset resulted heterogeneous for clinical data, resembling the characteristics of the tumor. DNA from the plasma was extracted to analyze copy number variations of the erbB2 gene using real-time PCR assays. Results: The real-time PCR assays for erbB2 gene showed significant (P = 0.001) copy number variations in the plasma of patients with esophageal carcinoma, as compared to healthy controls with high sensitivity (80%) and specificity (95%). These variations in erbB2 were negatively correlated to the progression free survival of these patients (P = 0.03), and revealed a further risk category stratification of patients with low VEGF expression levels. Conclusion: The copy number variation of erbB2 gene from plasma can be used as prognostic marker for early detection of patients at risk of worse clinical outcome in esophageal cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Hematology

Nobel prize in physiology or medicine 2021, receptors for temperature and touch: Implications for hematology

Immacolata Andolfo, Seth L. Alper, Achille Iolascon

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Letter Medical Laboratory Technology

Molecular detection of SARS-CoV-2 eta VOI in Northern Italy: a case report

Francesco Broccolo, Marta Giovanetti, Alessio Colombo, Nicola Perrelli, Adelaide Bussini, Silvia Cavalli, Massimo Ciccozzi, Massimo Zollo

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2022)

Article Genetics & Heredity

Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients

Stefania Mantovani, Sergio Daga, Chiara Fallerini, Margherita Baldassarri, Elisa Benetti, Nicola Picchiotti, Francesca Fava, Anna Galli, Silvia Zibellini, Mirella Bruttini, Maria Palmieri, Susanna Croci, Sara Amitrano, Diana Alaverdian, Katia Capitani, Simone Furini, Francesca Mari, Ilaria Meloni, Elisa Frullanti, Mario U. Mondelli, Alessandra Renieri

Summary: TLR7 variants in male patients lead to impaired immune response to viruses like SARS-CoV-2, resulting in severe COVID-19. These variants cause significant damage to the TLR7 signaling pathway and hinder the type I and II interferon responses.

GENES AND IMMUNITY (2022)

Article Biochemistry & Molecular Biology

Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients-A Target for SARS-CoV-2 Propagation

Veronica Ferrucci, Pasqualino de Antonellis, Fabrizio Quarantelli, Fatemeh Asadzadeh, Francesca Bibbo, Roberto Siciliano, Carmen Sorice, Ida Pisano, Barbara Izzo, Carmela Di Domenico, Angelo Boccia, Maria Vargas, Biancamaria Pierri, Maurizio Viscardi, Sergio Brandi, Giovanna Fusco, Pellegrino Cerino, Livia De Pietro, Ciro Furfaro, Leonardo Antonio Napolitano, Giovanni Paolella, Lidia Festa, Stefania Marzinotto, Maria Concetta Conte, Ivan Gentile, Giuseppe Servillo, Francesco Curcio, Tiziana de Cristofaro, Francesco Broccolo, Ettore Capoluongo, Massimo Zollo

Summary: The study found that subgenomic RNA transcripts (particularly sgN) can serve as markers of active SARS-CoV-2 virus replication and are correlated with high viral loads. The loss of sgN indicates the negativization of patient condition. A new detection kit has been developed to detect sgN, gene E, gene ORF1ab, and gene RNAse P. In addition, in vitro experiments showed that 2'-O-methyl antisense RNA related to the sgN sequence can inhibit SARS-CoV-2 N protein synthesis, viral replication, and syncytia formation in human cells, suggesting potential therapeutic applications against SARS-CoV-2.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Materials Science, Multidisciplinary

The physiological polyphosphate as a healing biomaterial for chronic wounds: Crucial roles of its antibacterial and unique metabolic energy supplying properties

Werner E. G. Mueller, Hadrian Schepler, Meik Neufurth, Shunfeng Wang, Veronica Ferrucci, Massimo Zollo, Rongwei Tan, Heinz C. Schroeder, Xiaohong Wang

Summary: The polyP hydrogel formulation can accelerate the healing of chronic wounds and provide more metabolic energy by encapsulating and killing bacteria.

JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY (2023)

Article Hematology

Duality of Nrf2 in iron-overload cardiomyopathy

Enrica Federti, Francesca Vinchi, Iana Iatcenko, Alessandra Ghigo, Alessandro Matte, Serge Cedrick Mbiandjeu Toya, Angela Siciliano, Deborah Chiabrando, Emanuela Tolosano, Steven Zebulon Vance, Veronica Riccardi, Immacolata Andolfo, Manuela Iezzi, Alessia Lamolinara, Achille Iolascon, Lucia De Franceschi

Summary: Cardiomyopathy greatly affects the well-being and survival of patients with 13-thalassemia or transfusion-dependent myelodysplastic syndromes. Recent research has found a connection between Nrf2 activity and iron metabolism. In this study, Nrf2-/- mice developed age-dependent cardiomyopathy characterized by oxidation, degradation of SERCA2A, and iron accumulation. The absence of Nrf2 paradoxically protected against heart iron accumulation when exposed to an iron overload diet. The activation of the unfolded protein response system and cardiac fibrosis were observed in a model of 13-thalassemia independent of heart iron content. These findings provide insights into potential early treatment for cardiomyopathy in patients with 13-thalassemia.

HAEMATOLOGICA (2023)

Article Genetics & Heredity

A Novel Variant in RAD21 in Cornelia De Lange Syndrome Type 4: Case Report and Bioinformatic Analysis

Alessandro De Falco, Daniele De Brasi, Matteo Della Monica, Claudia Cesario, Stefano Petrocchi, Antonio Novelli, Giuseppe D'Alterio, Achille Iolascon, Mario Capasso, Carmelo Piscopo

Summary: Cornelia de Lange Syndrome (CdLS) is a rare genetic disorder that affects multiple organs. This study presents clinical and genetic findings of a patient with CdLS type 4, a syndrome that has been rarely described before. The patient exhibited previously reported clinical features of CdLS type 4 as well as additional symptoms not mentioned previously. The novel genetic variant found in this patient suggests its pathogenicity. This report provides valuable insights for counseling future CdLS type 4 cases.

GENES (2023)

Article Oncology

Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology

Fabio Pastorino, Mario Capasso, Chiara Brignole, Vito A. Lasorsa, Veronica Bensa, Patrizia Perri, Sueva Cantalupo, Serena Giglio, Massimo Provenzi, Marco Rabusin, Elvira Pota, Monica Cellini, Annalisa Tondo, Maria A. De Ioris, Angela R. Sementa, Alberto Garaventa, Mirco Ponzoni, Loredana Amoroso

Summary: Approximately 50% of high-risk neuroblastomas (NB) relapse within two years after treatment, and additional therapeutic options are needed for relapsed or refractory patients. The identification of ALK somatic mutations or amplification is crucial for the treatment of these patients. ALK inhibitors may have a significant role in treating high-risk, ALK-mutated NB patients in the era of precision medicine.

CANCERS (2023)

Article Hematology

Proteome alterations in erythrocytes with PIEZO1 gain-of-function mutations

Immacolata Andolfo, Vittoria Monaco, Flora Cozzolino, Barbara Eleni Rosato, Roberta Marra, Vincenza Cerbone, Valeria Maria Pinto, Gian Luca Forni, Sule Unal, Achille Iolascon, Maria Monti, Roberta Russo

BLOOD ADVANCES (2023)

Letter Hematology

Coinheritance of PIEZO1 variants and multi-locus red blood cell defects account for the symptomatic phenotype in beta-thalassemia carriers

Valeria Maria Pinto, Roberta Russo, Sabrina Quintino, Barbara Eleni Rosato, Roberta Marra, Federica Del Giudice, Massimo Mogni, Massimo Maffei, Achille Iolascon, Gian Luca Forni, Immacolata Andolfo

Summary: This study provides an overview of the workflow and includes some examples of the achieved results.

AMERICAN JOURNAL OF HEMATOLOGY (2023)

Article Multidisciplinary Sciences

Label-free liquid biopsy through the identification of tumor cells by machine learning-powered tomographic phase imaging flow cytometry

Daniele Pirone, Annalaura Montella, Daniele G. Sirico, Martina Mugnano, Massimiliano M. Villone, Vittorio Bianco, Lisa Miccio, Anna Maria Porcelli, Ivana Kurelac, Mario Capasso, Achille Iolascon, Pier Luca Maffettone, Pasquale Memmolo, Pietro Ferraro

Summary: In this study, we introduce a machine learning-powered tomographic phase imaging flow cytometry system that can provide high-throughput 3D phase-contrast tomograms of individual cells for the identification of circulating tumor cells in microfluidic cytometry condition. We propose a hierarchical machine learning decision-maker that utilizes 3D morphological features calculated from the cells' refractive index to accurately discriminate tumor cells from white blood cells as well as identify the tumor type. Experimental results demonstrate a success rate of over 97% in identifying tumor cells and an accuracy of over 97% in discriminating between different cancer cell types, highlighting the potential of this stain-free liquid biopsy tool for detecting and classifying circulating tumor cells in blood.

SCIENTIFIC REPORTS (2023)

Article Genetics & Heredity

New Insights in 9q21.13 Microdeletion Syndrome: Genotype-Phenotype Correlation of 28 Patients

Alessandro De Falco, Achille Iolascon, Flora Ascione, Carmelo Piscopo

Summary: The use of array comparative genomic hybridization (array-CGH) has identified new microdeletion/microduplication syndromes, including the 9q21.13 microdeletion syndrome. This syndrome involves the loss of a specific genomic region and is associated with developmental delay, intellectual disability, autistic behavior, seizures, facial dysmorphism, myopia, and previously unreported brain anomalies. A study of 28 patients, including our case, allowed for the classification and analysis of candidate genes, as well as the correlation between genotype and phenotype. These findings provide a better understanding of the syndromic spectrum of 9q21.13 microdeletion syndrome and suggest the need for regular ophthalmological and neurological monitoring.

GENES (2023)

Review Genetics & Heredity

Epigenetics and immune cells in medulloblastoma

Francesca Gorini, Marco Miceli, Pasqualino de Antonellis, Stefano Amente, Massimo Zollo, Veronica Ferrucci

Summary: Medulloblastoma (MB) is a childhood tumor of the cerebellum that has been classified into four molecular subgroups and further divided into biologically distinct subtypes. The brain tumor microenvironment (BTME) plays a crucial role in regulating cancer progression in MB by influencing immune cells. Previously, MB was considered to have a low influx of immune cells, but recent studies have shown the presence of immunosuppressive immune cells in the BTME. This article provides an overview of the epigenetic alterations in MB and explores the potential of new immunotherapeutic approaches to target these immunosuppressive cells.

FRONTIERS IN GENETICS (2023)

No Data Available